Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Pharmacotherapy
List of Issues
Volume 24, Issue 10

Expert Opinion on Pharmacotherapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Pharmacotherapy, Volume 24, Issue 10 (2023)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Pharmacotherapy, Volume 24, Issue 10 (2023)

See all volumes and issues

Vol 25, 2024 Volume 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

What impact will BRAF/MEK-inhibitors have on the melanoma treatment armamentarium and are there challenges ahead?

Piotr Rutkowski & Paweł Rogala

Pages: 1101-1103

Published online: 08 May 2023

First Page PreviewforWhat impact will BRAF/MEK-inhibitors have on the melanoma treatment armamentarium and are there challenges ahead? | Full Text | References | PDF (170.1 KB) | EPUB

1454 Views
0 CrossRef citations
0Altmetric

Free Access

Drug Evaluation

Review Article

Evaluating everolimus for the treatment of breast cancer

Camille Moreau-Bachelard, Marie Robert, Carole Gourmelon, Emmanuelle Bourbouloux, Anne Patsouris, Jean-Sébastien Frenel & Mario Campone

Pages: 1105-1111

Published online: 18 May 2023

AbstractforEvaluating everolimus for the treatment of breast cancer | Full Text | References | PDF (338.2 KB) | EPUB

189 Views
0 CrossRef citations
0Altmetric

Review

Review Article

Current treatment options for Mycobacterium marinum cutaneous infections

Marina Medel-Plaza & Jaime Esteban

Pages: 1113-1123

Published online: 10 May 2023

AbstractforCurrent treatment options for Mycobacterium marinum cutaneous infections | Full Text | References | PDF (2.5 MB) | EPUB

222 Views
0 CrossRef citations
0Altmetric

Review Article

An update on current and emerging drug treatments for idiopathic pulmonary fibrosis

Athina Trachalaki, Nadiya Sultana & Athol Umfrey Wells

Pages: 1125-1142

Published online: 17 May 2023

AbstractforAn update on current and emerging drug treatments for idiopathic pulmonary fibrosis | Full Text | References | PDF (442.8 KB) | EPUB

568 Views
0 CrossRef citations
0Altmetric

Review Article

Current and emerging pharmacological treatments for respiratory syncytial virus infection in high-risk infants

Jorge A. Soto, Ricardo A. Loaiza, Sebastián Echeverría, Robinson A. Ramírez & Alexis M. Kalergis

Pages: 1143-1158

Published online: 16 May 2023

AbstractforCurrent and emerging pharmacological treatments for respiratory syncytial virus infection in high-risk infants | Full Text | References | PDF (2.2 MB) | EPUB

236 Views
0 CrossRef citations
0Altmetric

Review Article

Pharmacological management of digital ulcers in systemic sclerosis - what is new?

Ariane L. Herrick & Mariana Philobos

Pages: 1159-1170

Published online: 09 Jun 2023

AbstractforPharmacological management of digital ulcers in systemic sclerosis - what is new? | Full Text | References | PDF (3 MB) | EPUB

1551 Views
0 CrossRef citations
0Altmetric

Open Access

Review Article

Advancements in the pharmacological management of sepsis in the elderly

Christos Psarrakis & Evangelos J. Giamarellos-Bourboulis

Pages: 1171-1187

Published online: 15 May 2023

AbstractforAdvancements in the pharmacological management of sepsis in the elderly | Full Text | References | PDF (518 KB) | EPUB

268 Views
0 CrossRef citations
0Altmetric

Review Article

An overview of 5-HT₃ receptor antagonists as a treatment option for irritable bowel syndrome with diarrhea

Karolina Merecz, Mikołaj Hirsa, Olga Biniszewska, Jakub Fichna & Aleksandra Tarasiuk

Pages: 1189-1198

Published online: 25 May 2023

AbstractforAn overview of 5-HT₃ receptor antagonists as a treatment option for irritable bowel syndrome with diarrhea | Full Text | References | PDF (2 MB) | EPUB

194 Views
0 CrossRef citations
0Altmetric

Review Article

Metformin as a potential treatment for COVID-19

Matthew W. MCCarthy

Pages: 1199-1203

Published online: 18 May 2023

AbstractforMetformin as a potential treatment for COVID-19 | Full Text | References | PDF (266.4 KB) | EPUB

280 Views
0 CrossRef citations
0Altmetric

Original Research

Article

Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy

Madeline Merkel, David Danese, Chongshu Chen, Jessie Wang, Aozhou Wu, Hongbo Yang & Hollis Lin

Pages: 1205-1214

Published online: 26 May 2023

2689 Views
0 CrossRef citations
0Altmetric

Open Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents

Margherita Gobbo et al.

Review Article | Published online: 29 May 2024

A Systematic Review on Safety and Efficacy of Migalastat for the treatment of Fabry’s Disease

Haya Majid et al.

Review Article | Published online: 29 May 2024

Empagliflozin increases plasma levels of citrulline, histidine, and α-aminobutyric acid in patients with type 2 diabetes: effects of a sodium-glucose co-transporter 2 inhibitor on the plasma amino acid profile

Teruo Jojima et al.

Article | Published online: 29 May 2024

Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Rizwana Parveen et al.

Review Article | Published online: 28 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Pharmacotherapy (Vol.24, Iss.10, 2023)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?